PALI (Palisade Bio) FCF Yield % : -373.56 (As of Apr. 04, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Palisade Bio's Trailing 12-Month Free Cash Flow is $-12.19 Mil, and Market Cap is $3.26 Mil. Therefore, Palisade Bio's FCF Yield % for today is -373.56%.

The historical rank and industry rank for Palisade Bio's FCF Yield % or its related term are showing as below:

PALI' s FCF Yield % Range Over the Past 10 Years
Min: -2698.41 Med: -316.08 Max: -83.57
Current: -373.56

During the past 5 years, the highest FCF Yield % of Palisade Bio was -83.57%. The lowest was -2698.41%. And the median was -316.08%.

PALI's FCF Yield % is ranked worse than
95.59% of 1497 companies
in the Biotechnology industry
Industry Median: -15.53 vs PALI: -373.56

Palisade Bio's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

Palisade Bio FCF Yield % Historical Data

The historical data trend for Palisade Bio's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio FCF Yield % Chart

Palisade Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

-6.92

-43.29

-153.84

-248.90

Palisade Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial														-151.73	-202.17	-266.74	-252.33	-194.41

Competitive Comparison of Palisade Bio's FCF Yield %

For the Biotechnology subindustry, Palisade Bio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Palisade Bio's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Palisade Bio's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Palisade Bio's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Palisade Bio FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Palisade Bio's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-12.193	/	4.89885
	=	-248.90%

Palisade Bio's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-2.381	*	4	/	4.89885
	=	-194.41%

Palisade Bio FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Palisade Bio FCF Yield % Related Terms

Thank you for viewing the detailed overview of Palisade Bio's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Palisade Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (NAS:PALI) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7750 El Camino Real, Suite 2A, Carlsbad, CA, USA, 92009

Website

https://www.palisadebio.com

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Executives

Donald Allen Williams	director	C/O PRYOR CASHMAN LLP, 7 TIMES SQUARE, NEW YORK NY 10036
John David Finley	officer: Chief Financial Officer	C/O SENECA BIOPHARMA, INC., 20271 GOLDENROD LANE, GERMANTOWN MD 20876
Robert J. Trenschel	director	C/O SENECA BIOPHARMA, INC., 20271 GOLDENROD LANE, GERMANTOWN MD 20876
Mitchell Lawrence Jones	officer: Chief Medical Officer	70 GALLOUPES POINT ROAD, SWAMPSCOTT MA 01907
Robert Curtis Mcrae	officer: Chief Operating Officer	675 S. SIERRA AVE,, UNIT 23, SOLANA BEACH CA 92075
Thomas Hallam	director, officer: Chief Executive Officer	C/O SENECA BIOPHARMA, INC., 20271 GOLDENROD LANE, GERMANTOWN MD 20876
Michael John Dawson	officer: Chief Medical Officer	C/O SENECA BIOPHARMA, INC., 20271 GOLDENROD LANE, GERMANTOWN MD 20876
Yuma Regional Medical Center	10 percent owner	2400 S AVENUE A, YUMA AZ 85364
Stephanie Diaz	director	C/O SENECA BIOPHARMA, INC., 20271 GOLDENROD LANE, GERMANTOWN MD 20876
James R Neal	director	2910 SEVENTH STREET, BERKELEY CA 94710
Mary Ann Gray	director	201 W 70TH ST, SUITE 23K, NEW YORK NY 10023
David J Mazzo	director	110 ALLEN ROAD, 2ND FLOOR, BASKING RIDGE NJ 07920
Binxian Wei	director	P.O. BOX 2231, LIVINGSTON NJ 07039
Kenneth C Carter	director, officer: Executive Chairman	20358 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Cristina Csimma	director	14 CAMBRIDGE CENTER, BLDG 1, CAMBRIDGE MA 02142